| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
300,672,000 |
| Market
Cap: |
441.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.36 - $14.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 7.8 |
| Insider 6 Months : 7.8 |
| Insider 3/6 Months : 16 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
40,000 |
40,000 |
40,000 |
40,000 |
| Total Buy Value |
$176,160 |
$176,160 |
$176,160 |
$176,160 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
192,570 |
243,582 |
436,886 |
654,669 |
| Total Sell Value |
$1,111,017 |
$1,552,073 |
$3,531,312 |
$5,254,296 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
11 |
13 |
20 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Phillips James Michael |
SVP, Research & Development |
• – – |
2020-03-24 |
4 |
S |
$3.05 |
$8,421 |
D/D |
(2,760) |
249,220 |
|
-28% |
|
| Hunkapiller Michael |
CEO & President |
• • – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
2,623,215 |
|
- |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2020-02-20 |
4 |
S |
$4.50 |
$749,754 |
I/I |
(166,575) |
1,868,395 |
|
23% |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2020-02-20 |
4 |
S |
$4.48 |
$22,624 |
D/D |
(5,050) |
251,980 |
|
23% |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2020-02-19 |
4 |
S |
$4.44 |
$55,758 |
D/D |
(12,558) |
874,812 |
|
23% |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2020-02-19 |
4 |
S |
$4.49 |
$342,349 |
I/I |
(76,281) |
2,034,970 |
|
23% |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
257,030 |
|
- |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
887,370 |
|
- |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2020-02-18 |
4 |
S |
$4.49 |
$2,363,296 |
I/I |
(525,995) |
2,111,251 |
|
25% |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
237,030 |
|
- |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2019-02-19 |
4 |
S |
$7.17 |
$51,817 |
D/D |
(7,231) |
229,530 |
|
- |
|
| Ordonez Kathy |
Director |
– • – |
2019-02-19 |
4 |
S |
$7.17 |
$49,696 |
D/D |
(6,933) |
56,767 |
|
- |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2019-02-19 |
4 |
S |
$7.16 |
$85,851 |
D/D |
(11,987) |
737,370 |
|
- |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2019-02-19 |
4 |
S |
$7.19 |
$95,825 |
D/D |
(13,335) |
2,398,215 |
|
- |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
21,605 |
236,761 |
|
- |
|
| Ordonez Kathy |
Director |
– • – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,950 |
63,700 |
|
- |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,200 |
749,357 |
|
- |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
61,550 |
2,411,550 |
|
- |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2018-12-20 |
4 |
OE |
$2.27 |
$1,356,129 |
D/D |
316,990 |
708,157 |
|
- |
|
| Ordonez Kathy |
Chief Commercial Officer |
• • – |
2018-11-27 |
4 |
S |
$7.54 |
$188,500 |
D/D |
(25,000) |
43,750 |
|
- |
|
| Ordonez Kathy |
Chief Commercial Officer |
• • – |
2018-11-27 |
4 |
OE |
$2.90 |
$72,500 |
D/D |
25,000 |
68,750 |
|
- |
|
| Hunkapiller Michael |
Chairman, CEO & President |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
2,350,000 |
|
- |
|
| Barnes Susan K |
EVP, CFO and PAO |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
391,167 |
|
- |
|
| Ordonez Kathy |
Chief Commercial Officer |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
43,750 |
|
- |
|
| Phillips James Michael |
SVP, Research & Development |
• – – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
209,166 |
|
- |
|
239 Records found
|
|
Page 6 of 10 |
|
|
0.09 (6.52%) 
